Recent advances in the diagnosis and management of malignant pleural effusions

Mayo Clinic Proceedings

Volumn 83, Issue 2, 2008, Pages 235-250

  Heffner, John E ^a,c   Klein, Jeffrey S ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SURVIVAL; CONFERENCE PAPER; GASTROINTESTINAL CARCINOMA; HUMAN; LUNG CARCINOMA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; MESOTHELIOMA; OVARY CARCINOMA; PATHOGENESIS; PLEURA EFFUSION; PLEURODESIS; THORACOSCOPY; THORAX CANCER;

EID: 39749099436     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.2.235     Document Type: Conference Paper

References (224)

1. CI Henschke DF Yankelevitz SD Davis Pleural diseases: multimodality imaging and clinical management Curr Probl Diagn Radiol 20 5 1991 155 181
2. DD Storey DE Dines DT Coles Pleural effusion: a diagnostic dilemma JAMA 236 19 1976 2183 2186
3. E Martinez-Moragon J Aparicio J Sanchis R Menendez M Cruz Rogado F Sanchis Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases Respiration 65 2 1998 108 113
4. FH Hausheer JW Yarbro Diagnosis and treatment of malignant pleural effusion Cancer Metastasis Rev 6 1 1987 23 40
5. A Awasthi N Gupta R Srinivasan R Nijhawan A Rajwanshi Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India Cytopathology 18 1 2007 28 32
6. R Ismail-Khan LA Robinson CC Williams Jr CR Garrett G Bepler GR Simon Malignant pleural mesothelioma: a comprehensive review Cancer Control 13 4 2006 255 263
7. JE Heffner PJ Nietert C Barbieri Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions Chest 117 1 2000 79 86
8. E Boulanger L Gerard J Gabarre Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS J Clin Oncol 23 19 2005 4372 4380
9. DK Das Serous effusions in malignant lymphomas: a review Diagn Cytopathol 34 5 2006 335 347
10. TW Rice RM Rodriguez R Barnette RW Light Prevalence and characteristics of pleural effusions in superior vena cava syndrome Respirology 11 3 2006 299 305
11. SA Sahn State of the art: the pleura Am Rev Resp Dis 138 1 1988 184 234
12. H Asakura T Togami M Mitani Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma Ann Nucl Med 19 8 2005 725 728
13. YC Lee RW Light AW Musk Management of malignant pleural mesothelioma: a critical review Curr Opin Pulm Med 6 4 2000 267 274
14. W Chen CS Shih YT Wang GC Tseng WH Hsu Angiosarcoma with pulmonary metastasis presenting with spontaneous bilateral pneumothorax in an elderly man J Formos Med Assoc 105 3 2006 238 241
15. PE Postmus E Brambilla K Chansky International Association for the Study of Lung Cancer International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer J Thorac Oncol 2 8 2007 686 693
16. CC Blackmore WC Black RV Dallas HC Crow Pleural fluid volume estimation: a chest radiograph prediction rule Acad Radiol 3 2 1996 103 109
17. NR Qureshi FV Gleeson Imaging of pleural disease Clin Chest Med 27 2 2006 193 213
18. I Kocijancic K Vidmar Z Ivanovi-Herceg Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions J Clin Ultrasound 31 2 2003 69 74
19. PH Mayo P Doelken Pleural ultrasonography Clin Chest Med 27 2 2006 215 227
20. CF Chian WL Su LH Soh HC Yan WC Perng CP Wu Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies Chest 126 1 2004 129 134
21. AN Leung NL Müller RR Miller CT in differential diagnosis of diffuse pleural disease AJR Am J Roentgenol 154 3 1990 487 492
22. U Yilmaz G Polat N Sahin O Soy U Gulay CT in differential diagnosis of benign and malignant pleural disease Monaldi Arch Chest Dis 63 1 2005 17 22
23. ZC Traill RJ Davies FV Gleeson Thoracic computed tomography in patients with suspected malignant pleural effusions Clin Radiol 56 3 2001 193 196
24. JH Hwang KS Song SI Park TH Lim KH Kwon DE Goo Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT Korean J Radiol 6 2 2005 94 101
25. JG Lorigan HI Libshitz MR imaging of malignant pleural mesothelioma J Comput Assist Tomogr 13 4 1989 617 620
26. SD Davis CL Henschke DF Yankelevitz PT Cahill Y Yi MR imaging of pleural effusions J Comput Assist Tomogr 14 2 1990 192 198
27. F Falaschi L Battolla V Zampa Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases [in Italian] Radiol Med (Torino) 92 6 1996 713 718
28. J Hierholzer L Luo RC Bittner MRI and CT in the differential diagnosis of pleural disease Chest 118 3 2000 604 609
29. L Luo J Hierholzer RC Bittner J Chen L Huang Magnetic resonance imaging in distinguishing malignant from benign pleural disease Chin Med J (Engl) 114 6 2001 645 649
30. TC McLoud CT and MR in pleural disease Clin Chest Med 19 2 1998 261 276
31. B Duysinx D Nguyen R Louis Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging Chest 125 2 2004 489 493
32. JJ Erasmus HP McAdams SE Rossi PC Goodman RE Coleman EF Patz FDG PET of pleural effusions in patients with non-small cell lung cancer AJR Am J Roentgenol 175 1 2000 245 249
33. GJ Schaffler G Wolf H Schoellnast Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET Radiology 231 3 2004 Jun 858 865 Epub 2004 Apr 22.
34. BH Kwek SL Aquino AJ Fischman Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis Chest 125 6 2004 2356 2360
35. RF Munden A new era in thoracic oncologic imaging: CT-PET [editorial] J Thorac Imaging 21 2 2006 97 98
36. JS Toaff U Metser M Gottfried Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography Invest Radiol 40 4 2005 204 209
37. N Weiss SB Solomon Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography Clin Nucl Med 28 10 2003 811 814
38. BA Dwamena SS Sonnad JO Angobaldo RL Wahl Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT Radiology 213 2 1999 530 536
39. SH Feinsilver AA Barrows SS Braman Fiberoptic bronchoscopy and pleural effusion of unknown origin Chest 90 4 1986 516 519
40. B Chakrabarti I Ryland J Sheard CJ Warburton JE Earis The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions Chest 129 6 2006 1549 1555
41. TW Thomsen J DeLaPena GS Setnik Videos in clinical medicine: thoracentesis N Engl J Med 355 15 2006 e16
42. AH Diacon MM Schuurmans J Theron PT Schubert CA Wright CT Bolliger Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists Respiration 71 5 2004 519 522
43. D Feller-Kopman Therapeutic thoracentesis: the role of ultrasound and pleural manometry Curr Opin Pulm Med 13 4 2007 312 318
44. D Feller-Kopman Ultrasound-guided thoracentesis Chest 129 6 2006 1709 1714
45. TW Barnes TI Morgenthaler EJ Olson GK Hesley PA Decker JH Ryu Sonographically guided thoracentesis and rate of pneumothorax J Clin Ultrasound 33 9 2005 442 446
46. JS Ryu ST Ryu YS Kim JH Cho HL Lee What is the clinical significance of transudative malignant pleural effusion? Korean J Intern Med 18 4 2003 230 233
47. JM Porcel M Alvarez A Salud M Vives Should a cytologic study be ordered in transudative pleural effusions [letter]? Chest 116 6 1999 1836 1837
48. JE Heffner K Highland LK Brown A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates Am J Respir Crit Care Med 167 12 2003 1591 1599
49. JE Heffner LK Brown CA Barbieri Primary Study Investigators Diagnostic value of tests that discriminate between exudative and transudative pleural effusions Chest 111 4 1997 970 980
50. SM Matthai U Kini Diagnostic value of eosinophils in pleural effusion: a prospective study of 26 cases Diagn Cytopathol 28 2 2003 96 99
51. MA Martinez-Garcia E Cases-Viedma PJ Cordero-Rodriguez Diagnostic utility of eosinophils in the pleural fluid Eur Respir J 15 1 2000 166 169
52. JB Rubins HB Rubins Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study Chest 110 5 1996 1271 1274
53. P Branca RM Rodriguez JT Rogers DS Ayo JP Moyers RW Light Routine measurement of pleural fluid amylase is not indicated Arch Intern Med 161 2 2001 228 232
54. V Villena V Perez F Pozo Amylase levels in pleural effusions: a consecutive unselected series of 841 patients Chest 121 2 2002 470 474
55. SA Sahn JT Good Jr Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications Ann Intern Med 108 3 1988 345 349
56. A Gottehrer DA Taryle CE Reed SA Sahn Pleural fluid analysis in malignant mesothelioma: prognostic implications Chest 100 4 1991 1003 1006
57. JT Good Jr DA Taryle RM Maulitz RL Kaplan SA Sahn The diagnostic value of pleural fluid pH Chest 78 1 1980 55 59
58. A Sanchez-Armengol F Rodriguez-Panadero Survival and talc pleurodesis in metastatic pleural carcinoma, revisited: report of 125 cases Chest 104 5 1993 1482 1485
59. JE Heffner PJ Nietert C Barbieri Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data Chest 117 1 2000 87 95
60. JE Heffner JN Heffner LK Brown Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions Chest 123 6 2003 1887 1894
61. KV Nance RW Shermer FB Askin Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination Mod Pathol 4 3 1991 320 324
62. UB Prakash HM Reiman Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases Mayo Clin Proc 60 3 1985 158 164
63. M Woenckhaus U Grepmeier B Werner Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology J Mol Diagn 7 4 2005 517 524
64. S Benlloch JM Galbis-Caravajal C Martin Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion Cancer 107 8 2006 1859 1865
65. SM Sallach JA Sallach E Vasquez L Schultz P Kvale Volume of pleural fluid required for diagnosis of pleural malignancy Chest 122 6 2002 1913 1917
66. KC Ong V Indumathi WT Poh YY Ong The diagnostic yield of pleural fluid cytology in malignant pleural effusions Singapore Med J 41 1 2000 19 23
67. LW Garcia BS Ducatman HH Wang The value of multiple fluid specimens in the cytological diagnosis of malignancy Mod Pathol 7 6 1994 665 668
68. JM Porcel M Vives A Esquerda A Salud B Perez F Rodriguez-Panadero Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions Chest 126 6 2004 1757 1763
69. JH Lee JH Chang Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer Chest 128 4 2005 2298 2303
70. D Shitrit B Zingerman AB Shitrit D Shlomi MR Kramer Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature Oncologist 10 7 2005 501 507
71. D Whitaker The cytology of malignant mesothelioma Cytopathology 11 3 2000 139 151
72. BW Robinson RA Lake Advances in malignant mesothelioma N Engl J Med 353 15 2005 1591 1603
73. JH Lee YS Hong JS Ryu JH Chang p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion Lung Cancer 44 1 2004 33 42
74. MV Brock CM Hooker R Yung Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg 80 4 2005 1241 1247
75. AJ Holloway DS Diyagama K Opeskin A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions Clin Cancer Res 12 17 2006 5129 5135
76. MS Hung CK Lin SW Leu MY Wu YH Tsai CT Yang Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions Chang Gung Med J 29 4 2006 373 379
77. W Pao TY Wang GJ Riely KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib PLoS Med 2 1 2005 Jan e17 Epub 2005 Jan 25.
78. M Nakamoto H Teramoto S Matsumoto T Igishi E Shimizu K-ras and rho A mutations in malignant pleural effusion Int J Oncol 19 5 2001 971 976
79. BW Robinson J Creaney R Lake Mesothelin-family proteins and diagnosis of mesothelioma Lancet 362 9396 2003 1612 1616
80. A Cristaudo R Foddis A Vivaldi Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer Clin Cancer Res 13 17 2007 5076 5081
81. J Creaney I van Bruggen M Hof Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma Chest 132 4 2007 Oct 1239 1246 Epub 2007 Jul 23.
82. HI Pass D Lott F Lonardo Asbestos exposure, pleural mesothelioma, and serum osteopontin levels N Engl J Med 353 15 2005 1564 1573
83. EM Posadas F Simpkins LA Liotta C MacDonald EC Kohn Proteomic analysis for the early detection and rational treatment of cancer—realistic hope? Ann Oncol 16 1 2005 16 22
84. M Fiegl The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion Curr Opin Pulm Med 11 4 2005 313 318
85. MC Osterheld C Liette M Anca Image cytometry: an aid for cytological diagnosis of pleural effusions Diagn Cytopathol 32 3 2005 173 176
86. JK Northup SA Gadre Y Ge LH Lockhart GV Velagaleti Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition? Eur J Haematol 78 2 2007 152 156
87. C Boutin M Schlesser C Frenay P Astoul Malignant pleural mesothelioma Eur Respir J 12 4 1998 972 981
88. WM Edmondstone Investigation of pleural effusion: comparison between fibreoptic thoracoscopy, needle biopsy and cytology Respir Med 84 1 1990 23 26
89. AN McLean SR Bicknell LG McAlpine AJ Peacock Investigation of pleural effusion: an evaluation of the new Olympus LTF semiflexible thoracofiberscope and comparison with Abram's needle biopsy Chest 114 1 1998 150 153
90. NA Maskell FV Gleeson RJ Davies Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial Lancet 361 9366 2003 1326 1330
91. ADP Walshe JG Douglas KM Kerr ME McKean DJ Godden An audit of the clinical investigation of pleural effusion Thorax 47 9 1992 734 737
92. RL Cowie BC Escreet B Goldstein ME Langton RA Leigh Pleural biopsy: a report of 750 biopsies performed using Abrams's pleural biopsy punch S Afr Med J 64 3 1983 92 95
93. D Jimenez E Perez-Rodriguez G Diaz L Fogue RW Light Determining the optimal number of specimens to obtain with needle biopsy of the pleura Respir Med 96 1 2002 14 17
94. EM Scott TJ Marshall CD Flower S Stewart Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy Radiology 194 3 1995 867 870
95. RE Benamore K Scott CJ Richards JJ Entwisle Image-guided pleural biopsy: diagnostic yield and complications Clin Radiol 61 8 2006 700 705
96. GF Tassi RJ Davies M Noppen Advanced techniques in medical thoracoscopy Eur Respir J 28 5 2006 1051 1059
97. PN Mathur P Astoul C Boutin Medical thoracoscopy: technical details Clin Chest Med 16 3 1995 479 486
98. A Ernst CP Hersh F Herth A novel instrument for the evaluation of the pleural space: an experience in 34 patients Chest 122 5 2002 1530 1534
99. M Munavvar MA Khan J Edwards Z Waqaruddin J Mills The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur Respir J 29 3 2007 571 574 Epub 2007 Jan 10.
100. YC Lee RW Light Management of malignant pleural effusions Respirology 9 2 2004 148 156
101. NA Maskell RJ Butland BTS guidelines for the investigation of a unilateral pleural effusion in adults Thorax 58 suppl 2 2003 ii8 ii17
102. P Baas M Triesscheijn S Burgers R van Pel F Stewart M Aalders Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid Chest 129 3 2006 718 724
103. MG Chrysanthidis JP Janssen Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results Eur Respir J 26 6 2005 989 992
104. R Bueno J Reblando J Glickman MT Jaklitsch JM Lukanich DJ Sugarbaker Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma Ann Thorac Surg 78 5 2004 1774 1776
105. J Ferrer J Roldan J Teixidor E Pallisa I Gich F Morell Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy Chest 127 3 2005 1017 1022
106. SA Sahn Management of malignant pleural effusions Monaldi Arch Chest Dis 56 5 2001 394 399
107. JT Huggins P Doelken Pleural manometry Clin Chest Med 27 2 2006 229 240
108. D Feller-Kopman A Walkey D Berkowitz A Ernst The relationship of pleural pressure to symptom development during therapeutic thoracentesis Chest 129 6 2006 1556 1560
109. G Groth U Gatzemeier K Haussingen Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone) Ann Oncol 2 3 1991 213 215
110. G Antunes E Neville J Duffy N Ali BTS Pleural Disease Group, a subcommittee of the BTS Standards of Care Committee BTS guidelines for the management of malignant pleural effusions Thorax 58 suppl 2 2003 ii29 ii38
111. VB Antony R Loddenkemper P Astoul Management of malignant pleural effusions Eur Respir J 18 2 2001 402 419
112. EM Marom EF Patz Jr JJ Erasmus HP McAdams PC Goodman JE Herndon Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis Radiology 210 1 1999 277 281
113. M Schulze AS Boehle R Kurdow P Dohrmann D Henne-Bruns Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients Ann Thorac Surg 71 6 2001 1809 1812
114. GR Jones Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis Thorax 24 1 1969 69 73
115. CM Dresler J Olak JE Herndon II Cooperative Groups Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, North Central Cooperative Oncology Group, Radiation Oncology Therapy Group Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion Chest 127 3 2005 909 915
116. A Bernard RB de Dompsure O Hagry JP Favre Early and late mortality after pleurodesis for malignant pleural effusion Ann Thorac Surg 74 1 2002 213 217
117. CM Burrows WC Mathews HG Colt Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease Chest 117 1 2000 73 78
118. V Steger U Mika H Toomes Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses Ann Thorac Surg 83 6 2007 1940 1945
119. GW Boland GS Gazelle MJ Girard PR Mueller Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions AJR Am J Roentgenol 170 4 1998 943 946
120. YC Chang EF Patz Jr PC Goodman Pneumothorax after small-bore catheter placement for malignant pleural effusions AJR Am J Roentgenol 166 5 1996 1049 1051
121. J Heidecker JT Huggins SA Sahn P Doelken Pathophysiology of pneumothorax following ultrasound-guided thoracentesis Chest 130 4 2006 1173 1184
122. JT Huggins SA Sahn J Heidecker JG Ravenel P Doelken Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT Chest 131 1 2007 206 213
123. A Crnjac M Sok M Kamenik Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma Eur J Cardiothorac Surg 26 2 2004 432 436
124. YC Lee MH Baumann NA Maskell Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists Chest 124 6 2003 2229 2238
125. P Clementsen T Evald G Grode M Hansen G Krag Jacobsen P Faurschou Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter: a prospective randomized study Respir Med 92 3 1998 593 596
126. EF Patz Jr Malignant pleural effusions: recent advances and ambulatory sclerotherapy Chest 113 1 suppl 1998 74S 77S
127. EF Patz Jr HP McAdams JJ Erasmus Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage Chest 113 5 1998 1305 1311
128. W Parulekar G Di Primio F Matzinger C Dennie G Bociek Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions Chest 120 1 2001 19 25
129. WH Hsu CD Chiang CY Chen PC Kwan JY Hsu Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion Jpn J Clin Oncol 28 3 1998 187 191
130. U Sahin M Unlu A Akkaya Z Ornek The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions Respiration 68 5 2001 501 505
131. S Sartori P Tombesi D Tassinari Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions J Ultrasound Med 23 9 2004 1171 1176
132. L Saffran DE Ost AM Fein MJ Schiff Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter Chest 118 2 2000 417 421
133. A Goodman CW Davies Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial Lung Cancer 54 1 2006 Oct 51 55 Epub 2006 Aug 21.
134. E Yildirim K Dural R Yazkan Rapid pleurodesis in symptomatic malignant pleural effusion Eur J Cardiothorac Surg 27 1 2005 19 22
135. PA Spiegler AN Hurewitz ML Groth Rapid pleurodesis for malignant pleural effusions Chest 123 6 2003 1895 1898
136. EM Marom JJ Erasmus JE Herndon II C Zhang HP McAdams Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions AJR Am J Roentgenol 179 1 2002 105 108
137. JS Pollak Malignant pleural effusions: treatment with tunneled long-term drainage catheters Curr Opin Pulm Med 8 4 2002 302 307
138. G Verfaillie RV Herreweghe J Lamote M Noppen R Sacre Use of a Port-a-Cath system in the home setting for the treatment of symptomatic recurrent malignant pleural effusion Eur J Cancer Care (Engl) 14 2 2005 182 184
139. JM Alisky Implantable central venous access ports for minimally invasive repetitive drainage of pleural effusions Med Hypotheses 68 4 2007 910 911 Epub 2007 Jan 17.
140. CA Jacobi FA Wenger T Schmitz-Rixen JM Muller Talc pleurodesis in recurrent pleural effusions Langenbecks Arch Surg 383 2 1998 156 159
141. P Lee HG Colt A spray catheter technique for pleural anesthesia: a novel method for pain control before talc poudrage Anesth Analg 104 1 2007 198 200
142. HJ Mager B Maesen F Verzijlbergen F Schramel Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis Lung Cancer 36 1 2002 77 81
143. SR Dryzer ML Allen C Strange SA Sahn A comparison of rotation and nonrotation in tetracycline pleurodesis Chest 104 6 1993 1763 1766
144. C Tan A Sedrakyan J Browne S Swift T Treasure The evidence on the effectiveness of management for malignant pleural effusion: a systematic review Eur J Cardiothorac Surg 29 5 2006 May 829 838 Epub 2006 Apr 12.
145. LR Teixeira FS Vargas MM Acencio Influence of antiinflammatory drugs (methylprednisolone and diclofenac sodium) on experimental pleurodesis induced by silver nitrate or talc Chest 128 6 2005 4041 4045
146. LR Teixeira W Wu DS Chang RW Light The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits Chest 121 1 2002 216 219
147. C Xie LR Teixeira JP McGovern RW Light Systemic corticosteroids decrease the effectiveness of talc pleurodesis Am J Respir Crit Care Med 157 5, pt 1 1998 1441 1444
148. FJ Haddad RN Younes JL Gross D Deheinzelin Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial World J Surg 28 8 2004 Aug 749 753 Epub 2004 Aug 3.
149. H Liao Y Guo M Jun Na KB Lane RW Light The short-term administration of Ketoprofen does not decrease the effect of pleurodesis induced by talc or doxycycline in rabbits Respir Med 101 5 2007 963 968 Epub 2006 Oct 23.
150. LH Hsu TC Soong AC Feng MC Liu Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients J Thorac Oncol 1 5 2006 460 467
151. R Gasparri F Leo G Veronesi Video-assisted management of malignant pleural effusion in breast carcinoma Cancer 106 2 2006 271 276
152. K Arapis R Caliandro JB Stern P Girard D Debrosse D Gossot Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients Surg Endosc 20 2006 Jun 919 923 Epub 2006 May 2.
153. S Paschoalini Mda FS Vargas E Marchi Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions Chest 128 2 2005 684 689
154. A Marrazzo A Noto L Casa Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention J Pain Symptom Manage 30 1 2005 75 79
155. S Kolschmann A Ballin A Gillissen Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions Chest 128 3 2005 1431 1435
156. D Kilic H Akay S Kavukcu Management of recurrent malignant pleural effusion with chemical pleurodesis Surg Today 35 8 2005 634 638
157. A Stefani P Natali C Casali U Morandi Talc poudrage versus talc slurry in the treatment of malignant pleural effusion: a prospective comparative study Eur J Cardiothorac Surg 30 6 2006 827 832
158. JM Porcel A Salud M Nabal M Vives A Esquerda F Rodriguez-Panadero Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions Support Care Cancer 14 5 2006 May 475 478 Epub 2006 Jan 10.
159. JE Heffner RJ Standerfer J Torstveit L Unruh Clinical efficacy of doxycycline for pleurodesis Chest 105 6 1994 1743 1747
160. J Kuzdzal K Sladek D Wasowski Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial Med Sci Monit 9 6 2003 PI54 P159
161. S Sartori D Tassinari P Ceccotti Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions J Clin Oncol 22 7 2004 1228 1233
162. MJ Moffett JC Ruckdeschel Bleomycin and tetracycline in malignant pleural effusions: a review Semin Oncol 19 2 suppl 5 1992 59 62
163. V Ukale V Agrenius G Hillerdal D Mohlkert O Widstrom Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug Lung Cancer 43 3 2004 323 328
164. G Stiksa R Korsgaard BG Simonsson Treatment of recurrent pleural effusion by pleurodesis with quinacrine: comparison between instillation by repeated thoracenteses and by tube drainage Scand J Respir Dis 60 4 1979 197 205
165. TC Bayly DL Kisner A Sybert JS Macdonald E Tsou PS Schein Tetracycline and quinacrine in the control of malignant pleural effusions: a randomized trial Cancer 41 3 1978 1188 1192
166. S Koldsland JL Svennevig G Lehne E Johnson Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin Thorax 48 8 1993 790 793
167. AK Banerjee I Willetts JF Robertson RW Blamey Pleural effusion in breast cancer: a review of the Nottingham experience Eur J Surg Oncol 20 1 1994 33 36
168. CA Olivares-Torres R Laniado-Laborin C Chavez-Garcia C Leon-Gastelum A Reyes-Escamilla RW Light Iodopovidone pleurodesis for recurrent pleural effusions Chest 122 2 2002 581 583
169. R Agarwal AN Aggarwal D Gupta Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy Respirology 11 1 2006 105 108
170. R Agarwal AN Aggarwal D Gupta SK Jindal Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies Respir Med 100 11 2006 Nov 2043 2047 Epub 2006 Mar 30.
171. J Kelly-Garcia JF Roman-Berumen C Ibarra-Perez Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms Arch Med Res 28 4 1997 Winter 583 585
172. R Agarwal Iodopovidone: an inexpensive and effective agent for chemical pleurodesis [letter] Lung Cancer 55 2 2007 Feb 253 254 Epub 2006 Nov 21.
173. V Foresti Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions Respiration 62 1 1995 21 26
174. G Hillerdal J Kiviloog E Nou L Steinholtz Corynebacterium parvum in malignant pleural effusion: a randomized prospective study Eur J Respir Dis 69 3 1986 204 206
175. DT McLeod PM Calverley JW Millar NW Horne Further experience of Corynebacterium parvum in malignant pleural effusion Thorax 40 7 1985 515 518
176. A Senyigit H Bayram C Babayigit F Topcu AE Balci O Satici Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases Respiration 67 6 2000 623 629
177. A Chella A Ribechini P Dini C Adamo A Mussi CA Angeletti Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis [in Italian] Minerva Chir 49 11 1994 1077 1082
178. N Barbetakis T Antoniadis C Tsilikas Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer World J Surg Oncol 2 1 2004 16 10.1186/1477-7819-2-16
179. N Barbetakis M Vassiliadis K Kaplanis R Valeri C Tsilikas Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer BMC Palliat Care 3 1 2004 4 10.1186/1472-684X-3-4
180. J Kelly EC Holmes G Rosen Mitoxantrone for malignant pleural effusion due to metastatic sarcoma Surg Oncol 2 5 1993 299 301
181. HE Wilkins III MM Connolly P Grays G Marquez D Nelson Recombinant interferon alpha-2b in the management of malignant pleural effusions Chest 111 6 1997 1597 1599
182. S Sartori L Trevisani I Nielsen D Tassinari V Abbasciano Intracavitary bleomycin vs interferon in the management of malignant pleural effusions [letter] Chest 113 4 1998 1145 1146
183. S Ren DS Terman G Bohach Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer Chest 126 5 2004 1529 1539
184. A Ishida T Miyazawa Y Miyazu Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer Respirology 11 1 2006 90 97
185. T Seto S Ushijima H Yamamoto Kyushu Yamaguchi Thoracic Oncology Group Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial Br J Cancer 95 6 2006 Sep 18 717 721 Epub 2006 Aug 29.
186. K Kasahara K Shibata H Shintani Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer Anticancer Res 26 2B 2006 1495 1499
187. KT Luh PC Yang SH Kuo DB Chang CJ Yu LN Lee Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer: a randomized trial Cancer 69 3 1992 674 679
188. P Shaw R Agarwal Pleurodesis for malignant pleural effusions Cochrane Database Syst Rev 1 2004 CD002916.
189. A Debeljak P Kecelj N Triller Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions J BUON 11 4 2006 463 467
190. KC Ong V Indumathi J Raghuram YY Ong A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions Respirology 5 2 2000 99 103
191. N Nasreen KA Mohammed S Brown Talc mediates angiostasis in malignant pleural effusions via endostatin induction Eur Respir J 29 4 2007 Apr 761 769 Epub 2007 Jan 24.
192. E Marchi FS Vargas MM Acencio L Antonangelo EH Genofre LR Teixeira Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis Eur Respir J 28 5 2006 Nov 929 932 Epub 2006 Jul 26.
193. VB Antony N Nasreen KA Mohammed Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis [letter] Chest 126 5 2004 1522 1528
194. A Brant T Eaton Serious complications with talc slurry pleurodesis Respirology 6 3 2001 181 185
195. AR Medford NA Maskell A national survey of oncologist and chest physicians' attitudes towards empirical anti-oestrogen therapy, early pleurodesis and preference of sclerosing agent in malignant breast and ovarian pleural disease Palliat Med 19 5 2005 430 431
196. JR de Campos FS Vargas E de Campos Werebe Thoracoscopy talc poudrage: a 15-year experience Chest 119 3 2001 801 806
197. EM Scalzetti Unilateral pulmonary edema after talc pleurodesis J Thorac Imaging 16 2 2001 99 102
198. J Ferrer JF Montes MA Villarino RW Light J Garcia-Valero Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis Chest 122 3 2002 1018 1027
199. ME Froudarakis M Klimathianaki M Pougounias Systemic inflammatory reaction after thoracoscopic talc poudrage Chest 129 2 2006 356 361
200. JR Viallat F Rey P Astoul C Boutin Thoracoscopic talc poudrage pleurodesis for malignant effusions: a review of 360 cases Chest 110 6 1996 1387 1393
201. D Weissberg I Ben-Zeev Talc pleurodesis. Experience with 360 patients J Thorac Cardiovasc Surg 106 4 1993 689 695
202. M Noppen Who's (still) afraid of talc [editorial]? Eur Respir J 29 4 2007 619 621
203. JP Janssen G Collier P Astoul Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study Lancet 369 9572 2007 1535 1539
204. TJ Kuzniar MG Blum K Kasibowska-Kuzniar GM Mutlu Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis Ann Thorac Surg 82 6 2006 1976 1981
205. P Lee HG Colt Rigid and semirigid pleuroscopy: the future is bright Respirology 10 4 2005 418 425
206. MR Katlic Video-assisted thoracic surgery utilizing local anesthesia and sedation Eur J Cardiothorac Surg 30 3 2006 Sep 529 532 Epub 2006 Aug 2.
207. PP Brega-Massone C Lequaglie B Magnani F Ferro I Cataldo Chemical pleurodesis to improve patients' quality of life in the management of malignant pleural effusions: the 15 year experience of the National Cancer Institute of Milan Surg Laparosc Endosc Percutan Tech 14 2 2004 73 79
208. G Cardillo F Facciolo L Carbone Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions Eur J Cardiothorac Surg 21 2 2002 302 305
209. A Crnjac The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions Wien Klin Wochenschr 116 suppl 2 2004 28 32
210. D Trotter A Aly L Siu S Knight Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital's experience Heart Lung Circ 14 2 2005 93 97
211. LM van den Toorn E Schaap VF Surmont EM Pouw KC van der Rijt RJ van Klaveren Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter Lung Cancer 50 1 2005 123 127
212. JB Putnam Jr GL Walsh SG Swisher Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter Ann Thorac Surg 69 2 2000 369 375
213. JS Pollak CM Burdge M Rosenblatt JP Houston WJ Hwu J Murren Treatment of malignant pleural effusions with tunneled long-term drainage catheters J Vasc Interv Radiol 12 2 2001 201 208
214. A Tremblay G Michaud Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion Chest 129 2 2006 362 368
215. GW Pien MJ Gant CL Washam DH Sterman Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion Chest 119 6 2001 1641 1646
216. AI Musani AR Haas L Seijo M Wilby DH Sterman Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters Respiration 71 6 2004 559 566
217. C Ohm D Park M Vogen Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions Am Surg 69 3 2003 198 202
218. AM Wachsman EK Hoffer AR Forauer AM Silas JM Gemery Tension pneumothorax after placement of a tunneled pleural drainage catheter in a patient with recurrent malignant pleural effusions Cardiovasc Intervent Radiol 30 3 2007 531 533
219. SM Janes NM Rahman RJ Davies YC Lee Catheter-tract metastases associated with chronic indwelling pleural catheters Chest 131 4 2007 1232 1234
220. JB Putnam Jr RW Light RM Rodriguez A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions Cancer 86 10 1999 1992 1999
221. M Petrou D Kaplan P Goldstraw Management of recurrent malignant pleural effusions: the complementary role talc pleurodesis and pleuroperitoneal shunting Cancer 75 3 1995 801 805
222. O Genc M Petrou G Ladas P Goldstraw The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions Eur J Cardiothorac Surg 18 2 2000 143 146
223. O Artemiou GM Marta W Klepetko E Wolner MR Muller Pleurovenous shunting in the treatment of nonmalignant pleural effusion Ann Thorac Surg 76 1 2003 231 233
224. D Gupta K Ross V Piacentino III Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax Ann Thorac Surg 78 1 2004 e9 e12